Fabio Scirocchi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Recapitulating the human myotendinous junctionin vitrousing a 3D bioprinted model.

Recapitulating the human myotendinous junctionin vitrousing a 3D bioprinted model.

Journal: Biofabrication
Published: October 28, 2025

The Complexity of Malignant Glioma Treatment.

The Complexity of Malignant Glioma Treatment.

Journal: Cancers
Published: January 22, 2025

Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.

Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.

Journal: Cancers
Published: October 10, 2024

Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients.

Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients.

Journal: Frontiers in immunology
Published: August 21, 2024

Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation.

Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation.

Journal: Cancer discovery
Published: July 22, 2024

CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.

CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.

Journal: Journal of translational medicine
Published: February 05, 2024

Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.

Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.

Journal: Journal of translational medicine
Published: May 25, 2023

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.

Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.

Journal: Immunity
Published: March 21, 2023

Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.

Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.

Journal: International journal of molecular sciences
Published: March 02, 2023

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.

Journal: International journal of molecular sciences
Published: October 26, 2022

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.

Journal: International journal of molecular sciences
Published: April 14, 2022

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.

Immune effects of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: Relief from immunosuppression is associated with clinical response.

Journal: EBioMedicine
Published: November 23, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026